MNKD$3.935.36%0.20
After Hours: 3.90-0.03 -0.76%
Mannkind Corp (MNKD)
Date: 2026-11-04 16:00O: 3.86H: 4.05L: 3.80C: 3.93Vol: 3.818M
Mannkind Corp stock is traded at $3.93, with a volume of 3,818,154. It is up +5.36% in the last 24 hours and up +3.42% over the past month. MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.
Previous Close:
$3.73
Open:
$3.86
24h Volume:
3,818,154
Relative Volume:
1.27
Market Cap:
$1.26B
Revenue:
$360.78M
Net Income/Loss:
-$23.91M
P/E Ratio:
-
EPS:
-$0.0781
Net Cash Flow:
$13.07M
1W Performance:
+14.58%
1M Performance:
+3.42%
6M Performance:
+39.86%
1Y Performance:
-28.28%
1-Day Range:
$3.80$4.05
1-Week Range:
$3.45$4.05
52-Week Range:
$2.23$6.51
Mannkind Corp Stock (MNKD) Company Profile
Name
Mannkind CorpSector
HealthcareIndustry
BiotechnologyPhone
818-661-5000Address
1 CASPER STREET, DANBURY, CA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS
Mannkind Corp Stock (MNKD) Upgrades & Downgrades
Mannkind Corp Stock (MNKD) Financials Data
Mannkind Corp Stock (MNKD) Insider Trading
- STEVEN BINDERSep 25 '26Director
- Transaction
- Proposed Sale
- Cost
- $3.29
- #Shares
- 39,051
- Value ($)
- 128,478
- #Shares Total
- 0
- Binder Steven B.Sep 25 '26Director
- Transaction
- Sale
- Cost
- $3.29
- #Shares
- 39,051
- Value ($)
- 128,478
- #Shares Total
- 713,258
- STEVEN BINDERSep 10 '26Director
- Transaction
- Proposed Sale
- Cost
- $3.94
- #Shares
- 33,558
- Value ($)
- 132,219
- #Shares Total
- 0
- Binder Steven B.Sep 10 '26Director
- Transaction
- Sale
- Cost
- $3.81
- #Shares
- 33,558
- Value ($)
- 127,856
- #Shares Total
- 752,309
- STEVEN BINDERAug 07 '26Director
- Transaction
- Proposed Sale
- Cost
- $3.89
- #Shares
- 39,051
- Value ($)
- 151,908
- #Shares Total
- 0
- Binder Steven B.Aug 07 '26Director
- Transaction
- Sale
- Cost
- $4.06
- #Shares
- 39,051
- Value ($)
- 158,547
- #Shares Total
- 785,867
- DAVID THOMSONJul 17 '26Officer
- Transaction
- Proposed Sale
- Cost
- $4.04
- #Shares
- 24,109
- Value ($)
- 97,400
- #Shares Total
- 0
- STEVEN BINDERJul 17 '26Director
- Transaction
- Proposed Sale
- Cost
- $4.04
- #Shares
- 52,485
- Value ($)
- 212,039
- #Shares Total
- 0
- Thomson DavidJul 17 '26EVP Genl Counsel & Secretary
- Transaction
- Sale
- Cost
- $4.05
- #Shares
- 24,109
- Value ($)
- 97,641
- #Shares Total
- 797,554
- Binder Steven B.Jul 17 '26Director
- Transaction
- Sale
- Cost
- $4.06
- #Shares
- 52,485
- Value ($)
- 213,089
- #Shares Total
- 824,918
